Patrick Fruzzetti on Valuation Discipline, Agilent Stock, and Gold Holdings

Valuation Discipline Heading into Year-End

• 💡 Discipline around valuation is crucial as the year concludes, even with momentum in mega-cap tech.
• 🎯 Fundamentals still hold importance, despite the potential for investors to get carried away with market momentum.

Agilent Technologies: A Healthcare Play

• 🔬 Agilent's equipment analyzes a wide range of substances, including chemicals, food, water, cancer cells, and semiconductors.
• 🏥 Their equipment is utilized in hospitals, pharmaceutical facilities, and research labs, with a significant portion of revenue from a service model.
• 📈 The company is viewed as a healthcare tech company, with a bullish outlook based on historical healthcare sector outperformance during midterm election years, specifically looking towards 2026.

Macroeconomic Factors Influencing Agilent

• 🌍 Potential improvements in US-China trade relations and the resolution of a government shutdown are seen as positive catalysts.
• 🤝 Increased health insurance coverage, leading to more procedures, is also considered a factor that could boost Agilent's business.

Gold as a Portfolio Balance

• 💰 Gold is recommended as a core holding for portfolio balance, despite its significant year-to-date rally.
• 📊 It is noted as being underowned in most retail investor portfolios, suggesting continued positive sentiment.

Dollar Strength and Future Earnings

• 📉 A continued rise in the US dollar could negatively impact future earnings.
• ⚠️ However, the outlook for 2026 suggests continued deficit issues and downward pressure on the dollar, potentially easing this concern.